High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases
The FEBS Journal · 2026
DOI: 10.1111/febs.70348 ↗At a glance
Journal article in The FEBS Journal, 2026. Written by Amatzia Gantz and 9 co-authors. Institution: Department Anatomy and Cell Biology, McGill University, Quebec, Canada. Major MEDLINE topics: Colorectal Neoplasms, Liver Neoplasms, Cholesterol. Cited 5 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Cholesterol availability has been implicated in cancer progression. Here, we demonstrate the connection between blood cholesterol concentration, the development of distinct histopathological growth patterns (HGPs) in colorectal cancer liver metastases (CRCLM), and new avenues of treatment for patients. Our study reveals that serum cholesterol levels correlate with the different HGPs, and patients on statins had desmoplastic HGPs and improved overall survival. We also demonstrate, in an in vivo mouse model, that inhibition of key modulators of cholesterol metabolism, using antiproprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, attenuated the development of CRCLM tumors, as well as the formation of vessel co‐opting lesions. Our findings underscore the importance of cholesterol in CRCLM and the potential clinical application of evolocumab to mitigate the growth of these histological types of tumors in CRCLM.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department Anatomy and Cell Biology, McGill University, Quebec, Canada.
- Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Canada.
- Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute of Montreal, Canada.
ORCID profiles: Amatzia Gantz, Audrey Kapelanski-Lamoureux, Miran Rada, Lucyna Krzywon, Migmar Tsamchoe, Anastasia Tsatoumas, Stephanie K Petrillo, Nabil G Seidah, Anthoula Lazaris, Peter Metrakos
Cite
APA
Gantz, A., Kapelanski-Lamoureux, A., Rada, M., Krzywon, L., Tsamchoe, M., Tsatoumas, A., Petrillo, S. K., Seidah, N. G., Lazaris, A., & Metrakos, P. (2026). High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases. The FEBS Journal. https://doi.org/10.1111/febs.70348
Vancouver
Gantz A, Kapelanski-Lamoureux A, Rada M, Krzywon L, Tsamchoe M, Tsatoumas A, et al. High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases. The FEBS Journal. 2026. doi:10.1111/febs.70348
BibTeX
@article{Gantz2026,
author = {Gantz, Amatzia and Kapelanski-Lamoureux, Audrey and Rada, Miran and Krzywon, Lucyna and Tsamchoe, Migmar and Tsatoumas, Anastasia and Petrillo, Stephanie K and Seidah, Nabil G and Lazaris, Anthoula and Metrakos, Peter},
title = {High levels of serum cholesterol increase the risk of developing vessel co‐opting tumors in colorectal cancer liver metastases},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70348}
}
EUVIMED